Article content
The guidance is not binding but most provincial governments have indicated they were waiting for the information before setting their policies for second doses.
Manitoba didn’t wait for the report to be published, announcing Monday they would offer AstraZeneca recipients Pfizer or Moderna if they wanted.
Quebec currently recommends getting the same vaccine twice but says with informed consent people who got AstraZeneca first can get Pfizer or Moderna.
The province is expected to update this later in the week, along with shortening the wait to get second doses of mRNA vaccines.
NACI’s advice comes after interim results were published in May from two studies looking at mixing and matching vaccines.
Two mental-health-themed qualifications have recently been launched by CACHE. How useful will they be for practitioners who are now looking to mitigate the effects of the pandemic, asks Gabriella Jozwiak
Express News Service
NEW DELHI: Several countries are now weighing the option of mixing and matching Covid vaccines amid supply delays and safety concerns after evidence from scientific studies have indicated that it may work, but the proposition is not being explored in India presently, authorities told
The first findings of an Oxford University-led study, supported by another study in Spain, found that people who received Pfizer s vaccine followed by a dose of AstraZeneca s, or vice versa, were more likely to report mild or moderate common post-vaccination symptoms than if they received two of the same type.
Also, the combination of two vaccines showed that they were highly effective against Covid infection.
By Syndicated Content
May 24, 2021 | 5:09 AM
(Reuters) â A growing number of countries are looking at switching to different COVID-19 vaccines for second doses amid supply delays and safety concerns that have slowed their vaccination campaigns.
Several medical studies to test the efficacy of switching COVID-19 vaccines are under way.
The following are countries that are weighing, or have decided to adopt, such a solution:
CANADA Officials said in May that people who were inoculated with AstraZenecaâs COVID-19 shot may be offered a second dose of another vaccine, a move based on supply concerns as well as the rise in incidence of rare blood clots linked to first doses produced by the Anglo-Swedish drugmaker.
Reuters
6 minute read
A medical worker administers a dose of the Comirnaty Pfizer-BioNTech COVID-19 vaccine in a vaccination center in Paris as part of the coronavirus disease (COVID-19) vaccination campaign in France, May 12, 2021. REUTERS/Gonzalo Fuentes
A growing number of countries are looking at switching to different COVID-19 vaccines for second doses amid supply delays and safety concerns that have slowed their vaccination campaigns. read more
Several medical studies to test the efficacy of switching COVID-19 vaccines are under way. read more
The following are countries that are weighing, or have decided to adopt, such a solution:
CANADA Officials said in May that people who were inoculated with AstraZeneca s (AZN.L) COVID-19 shot may be offered a second dose of another vaccine, a move based on supply concerns as well as the rise in incidence of rare blood clots linked to first doses produced by the Anglo-Swedish drugmaker.